A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

Recruiting

Trial locations(14 sites)

United States

UCLA Neurology, Los Angeles, California

University of Colorado, Aurora, Colorado

University of Florida, Gainesville, Florida

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Austria

Medizinische Universität Innsbruck, Innsbruck

Belgium

HUB-Hôpital Erasme, Brussels

Czechia

Center for hereditary ataxias, Motol, Motol, Prague

Germany

Universitätsklinikum Tübingen, Tübingen, Baden-Würtemberg

University Hospital Aachen, Aachen

Klinikum der Universität München, Munich

Italy

Scientific Institute, IRCCS E. Medea, Conegliano

Fondazione I.R.C.C.S. Istituto Neurologico C. Besta, Milan

Ospedale Pediatrico Bambino Gesu, Rome

Netherlands

Stichting Radboud universitair medisch centrum, Nijmegen